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 ABSTRACT  
 
The interaction of partially reduced graphene oxide (prGO) and Huh7.5.1 liver cancer cells was 
investigated by means of DUV fluorescence bioimaging. The prGO sample was obtained by the 
reduction (to a certain extent) of the initially prepared graphene oxide (GO) nanosheets with 
hydrazine. The fluorescence of the GO nanosheets increases with time of the reduction due to a 
change in ratio of the sp2 and sp3 carbon sites and the prGO sample was extracted from the 
dispersion after 6 min, when the intensity of the fluorescence reached its maximum. The 
reduction process was left to proceed further to saturation until highly reduced graphene oxide 
(denoted here as rGO) was obtained. GO, prGO and rGO samples were investigated by structural 
(scanning electron microscopy (SEM), scanning transmission electron microscopy coupled with 
energy dispersive spectrometry (STEM-EDS)) and spectroscopic (UV-vis, photoluminescence 
(PL), Raman) methods. After that, Huh7.5.1 cells were incubated with GO, prGO and rGO 
nanosheets and used in bioimaging studies, which were performed on DISCO beamline of 
synchrotron SOLEIL. It was found that the prGO significantly enhanced the fluorescence of the 
cells and increased the intensity of the signal by ~2.5 times. Time-lapse fluorescence microscopy 
experiments showed that fluorescence dynamics strongly depends on the type of nanosheets 
used. The obtained prGO nanostructure can be easily conjugated with aromatic ring containing 
drugs, which opens a possibility for its applications in fluorescence microscopy monitored drug 
delivery. 
 
Keywords: bioimaging, graphene oxide, fluorescence, cancer, cells 
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 1. Introduction 
 
Graphene-based nanomaterials recently emerged as novel carriers in drug delivery 
applications [1,2]. Graphene oxide (GO) and reduced GO (rGO) display advantageous 
characteristics as biosensing platforms due to the high surface area, excellent biocompatibility 
and ability to interact with proteins and polysaccharides [3-5]. GO exhibits wide fluorescence 
emission (280 - 500 nm) [6] that can be used to track the transport of the graphene-based 
nanocarriers to the particular cells by means of fluorescent microscopy [7]. In fluorescent 
bioimaging, it is also important to use hydrophilic probes with well-defined sizes and specific 
optical properties. It was shown that the optical properties of GO could be controlled by 
changing its surface chemistry [8-10]. GO is an electronically hybrid material that possesses both 
conducting π-states from sp2 carbon sites and a large energy gap between the σ-states of its sp3-
bonded carbons. The control of the ratio of the sp2 and sp3 fractions by the reduction process 
enables one to tune its bandgap and, therefore, to controllably transform GO from an insulator to 
a graphene-like semi-conductor [11]. With the partial reduction of GO, it is possible to influence 
the size of sp2 clusters, which affects the fluorescence emission and enhances the quantum yield 
[8]. In the present study, we decided to investigate the interaction of this intermediate form, 
partially reduced graphene oxide (prGO), with cancer liver cells (Huh7.5.1 cell line) by using 
DUV fluorescence microscopy. We believe that the pronounced fluorescence of prGO will 
enable its easier detection in the certain cell compartments, which is very important if these 
nanostructures are going to be used in drug delivery applications.  
 The interaction of graphene-based nanosheets with live cells may induce significant 
changes in the functioning of the cells and distinct toxic effects. Previous optical microscopy 
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 studies revealed that GO and rGO are internalized in cells in a different way, while their toxicity 
is highly dependent on the presence of the surface oxygen groups [12,13]. The changes in the 
metabolism may be followed by observing the changes in the autofluorescence of the cells, since 
autofluorescent species, particularly aromatic amino acids and NADH, are involved in 
mitochondrial function, energy metabolism, calcium homeostasis, gene expression, oxidative 
stress, aging and apoptosis [14,15]. The study is focused on the fluorescence properties of the 
cancer Huh7.5.1 cells after their interaction with GO, prGO and rGO sheets. We also followed 
the changes in fluorescence dynamics of these graphene oxide-based species when they are in 
contact with the cells. 
 
2. Materials and methods 
 
2.1 Graphene oxide and the reduced graphene oxide 
Graphene oxide was synthesized by using modified Hummers method according to the 
procedure found in ref. [16]. A 150 g of expanded graphite (EG) was used as a starting material, 
while sulphuric acid (95-98% H2SO4, Sigma Aldrich) was used as the intercalating compound. 
Sulphuric acid (6 ml) was added to the pilled pieces of EG and mixed at 0 °C for two hours. The 
mixture was left overnight and kept at room temperature. Oxidation was carried out by adding 
450 mg of potassium permanganate (KMnO4). After adding 28 ml of DI water, the mixture was 
kept in oil bath at 90-95 °C for two hours. Then, the oxidized graphite mixture was cooled down 
to the room temperature. A possible reduction of the product was stopped by adding 84 ml of 3% 
solution of H2O2. Several cycles of centrifugation (at 5500 rpm) and washing with 5% HCl 
solution were conducted until brown solution of graphite oxide (GtO) was obtained. The 
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 sonication of GtO solution with Branson W-450 D Digital Soniﬁer with 20% amplitude (80W) 
for 10 minutes resulted in a change of colour from light brown to light yellow. Transparent light 
yellow supernatants of GO were obtained after another cycle of centrifugation and washing.  
The reduction of the obtained GO was carried out by using 30% solution of hydrazine 
hydrate (N2H4, Sigma Aldrich). First, the beaker with 0.1 mg/ml of GO solution was heated in oil 
bath at 95°C. After that, 100 l of hydrazine solution was added into heated GO solution to 
initiate the reduction process. At certain time intervals during the reduction, equal amounts of 
graphene oxide were extracted and diluted with DI water in order to stop the process. The 
partially reduced GO samples extracted at different reduction times were stable for more than a 
month after the preparation. The reduced GO sample was obtained at the end of the preparation 
procedure (after 45 min of reduction). It was less stable; the sheets tended to agglomerate after 
few days. This sample was studied immediately after its preparation. 
2.2 Methods  
The morphology of graphene oxide was investigated by using a JEOL JSM-6390 scanning 
electron microscope (SEM). Because of the low electrical conductivity of graphene oxide, the 
surface was covered with thin layer of gold. The micrographs of GO were obtained with x4300 
magnification and at operating voltage value of 13 kV. 
The structure and morphology of the GO, prGO and rGO samples were investigated by probe 
aberration corrected scanning transmission electron microscope (STEM) (FEI Titan 80-300) 
coupled with a SuperX energy dispersive spectrometer (SuperX EDS) with the four silicon drift 
detectors (SDD) (Bruker). Aqueous dispersions of the GO, prGO and rGO were deposited on 
carbon coated copper grids using an automatic pipette. The samples were left to dry under 
ambient conditions before they were transferred to the microscope chamber. 
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 A fully automated Raman microscope (LabRAM HR Evolution) was used for Raman 
spectroscopy measurements. The spectra were obtained over the Raman shift range from 1000 to 
2000 cm-1 using acquisition time of 10 s. The samples were excited by 532 nm laser light (with 
1.08 mW of incident power) and the data were collected by using a 50× objective. 
The UV–vis absorption measurements of the aqueous dispersions were carried out on a 
Thermo Evolution 600 spectrophotometer. 
The photoluminescence spectra of aqueous dispersions of GO, prGO and rGO were recorded 
using a PerkinElmer LS45 fluorescence spectrophotometer. Fluorescence excitation emission 
matrices were recorded on a Fluorolog-3 spectrofluorometer system (Model FL3-221, Horiba 
Jobin Yvon). Xenon lamp (450 W) was used as an excitation source. Both excitation and 
emission monochromators were double grating, with dispersion of 2.1 nm/mm (1200 
grooves/nm). All measurements were performed in the front face geometry at room temperature. 
To obtain the fluorescence excitation emission matrices, the emission spectra were recorded in 
the range from 330 to 650 nm at 2 nm steps and in the excitations range from 270 to 430 nm at 
2.5 nm steps. For these measurements, excitation slit was set at 6 nm, emission slit was at 2 nm 
and integration time was fixed to 0.4 ms. Variations of the excitation power were corrected using 
reference photodetector. 
2.3 Cell line and the preparation of biological samples  
Human hepatocellular carcinoma-derived Huh7.5.1 cells were routinely cultured as 
monolayer and were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal calf serum, penicillin and streptomycin. The cells were maintained at 37 °C in a 
humidified atmosphere of 5% CO2.  
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 For DUV fluorescence imaging studies, the Huh7.5.1 cells were plated in plastic Petri dishes 
containing 25 mm round quartz coverslip and incubated for 24 hours. Cell attachment was 
monitored by visible inspection using a microscope. Thereafter, cells were incubated with GO, 
prGO and rGO sheets for 5 hours. The cell’s culture medium (3 ml) was mixed with 300 µl of 
the GO, prGO and rGO dispersions (30 g/ml). After the incubation, the cells were washed with 
PBS, fixed with 4% of PFA, rinsed in distilled water and air dried before being used for 
bioimaging. The control sample was prepared in the same way but without adding GO, prGO or 
rGO. 
2.4 Deep-UV fluorescence microscopy  
The fluorescence images of Huh7.5.1 cells and Huh7.5.1 cells incubated with GO, prGO and 
rGO were acquired on TELEMOS endstation of DISCO beamline (SOLEIL synchrotron facility, 
France). Synchrotron light source was monochromatized to provide an excitation wavelength of 
270 nm and the flux of the beam was less than 7·1010 photons/s. DISCO beamline is optimized 
for the investigations of the biological samples and the intensity of the beam was adjusted to 
minimize the possibility of damaging the cells. The fluorescence of the control and incubated 
cells was collected in the [327 - 353 nm], [370 - 410 nm] and [420 - 480 nm] wavelength ranges 
for 30 seconds. To ensure consistency of the observations at least 30 different locations (80 x 80 
µm) were investigated. An ultrafluar 100x glycerin immersion objective (Zeiss, Germany) and 
PIXIS 1024-BUV EM-CCD camera (Princeton, USA) were used for recording images. Time-
lapse experiments were performed to study the fluorescence dynamics of the control and 
incubated cells. The evolution of the fluorescence signal was followed by recording the 
fluorescent image every 2 min for 30 s. FIJI software [17] was employed in order to analyse the 
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 obtained fluorescence images. The normalization of original intensities I was performed by using 
following formula: 
𝑓(𝑡𝑖) =  
𝐼(𝑡𝑖)−𝐼𝑚𝑖𝑛
𝐼𝑚𝑎𝑥−𝐼𝑚𝑖𝑛
,                                                              (1) 
where f(ti) are the normalized intensities with respect to the minimum (Imin) and maximum (Imax) 
values of the {I(ti)} set.  
 
3. Results and discussion 
 
3.1 Structure and optical properties of GO, prGO and rGO  
Modified Hummers method was used for the fabrication of graphene oxide and Figure 1 
shows the SEM micrograph of the obtained GO sample. The SEM image of a selected exfoliated 
thin sheet of GO is shown in Figure 1b.  
 
 
Fig. 1. a) Scanning electron microscopy (SEM) micrograph of the obtained GO sheets. B) Selected GO sheet at 
higher magnification. 
 
As stated in the introduction, the partial reduction of graphene oxide can be used to modify the 
optical properties of the sheets. It was shown that the reduction process is highly sensitive to the 
amount of reducing agent (hydrazine) [18-20]. A careful tuning of the concentration of hydrazine 
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 and the reduction conditions enabled the extraction of the intermediates with particular 
properties. The fluorescence measurements of the intermediate products of the reduction 
(Supporting information Figure S1) showed that the GO sample partially reduced for 6 min 
exhibited the highest fluorescence intensity. For this reason, the structural and optical 
measurements were focused on this particular sample (it will be referred in the text as prGO 
unless designated otherwise). Figure 2 shows high-resolution TEM micrographs of the initial 
GO, prGO and rGO samples.  
 
 
Fig. 2. HRTEM micrographs and elemental maps of carbon and oxygen for a) graphene oxide (GO), b) graphene 
oxide partially reduced for 6 min (prGO) and c) reduced graphene oxide (rGO). The elemental composition is 
determined for the selected areas on the sheets surfaces (green outlines). 
 
The elemental mappings of the highlighted surface areas are shown under the corresponding 
TEM images. The oxygen maps (red) reveal that the oxygen content decreases with the time of 
reduction (Figure 2). Thus the C/O ratio is increasing with reduction time, which is also 
confirmed by EDS results (Figure 3). Fabrication of graphene oxide led to stable 2d 
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 nanostructures with C/O∼4. After the reduction, C/O ratio increased to ∼7 for prGO and ∼10 for 
rGO. Finally, it is important to mention that the TEM studies reveal that the partial reduction 
with hydrazine did not induce visible damage of the layered structures of GO-based species. 
 
Fig. 3. Energy dispersive spectroscopy (EDS) spectra of a) GO b) prGO and c) rGO samples. The ratios of carbon 
and oxygen atoms increase with increasing in reduction time. 
 
The changes in carbon-oxygen ratios were also followed by Raman spectroscopy. Figure 4 
shows Raman spectra of the GO, prGO and rGO samples with typical D and G peaks at 
1345 cm-1 and 1588 cm-1 shifts, respectively. The G band originates from the in-plane vibrations 
of sp2 carbon atoms and represents doubly degenerate phonon mode (E2g symmetry) at the center 
of the Brillouin zone. On the other hand, the D peak (A1g symmetry mode) comes from the 
presence of the sp3 carbons and from the defect-induced breathing mode of sp2 rings [21,22]. 
Consequently, the reduction process can be followed by observing the changes in the relative 
intensity of these two bands (ID/IG). The ID/IG ratio of GO is 0.96 and increases after the 
reduction to 1.12 and 1.60 for prGO and rGO, respectively (Figure 4). The reduction affects the 
in-plane vibrations of sp2 carbon atoms, which is reflected in changes in the intensity of the G 
mode (Figure 4) [23,24]. Stankovich et al [25] attributed an increase in ID/IG ratio to a decrease 
in the average size of the sp2 domains upon reduction i.e. to the formation of new graphitic 
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 domains that are smaller in size (~2 nm) than those initially present in GO but, at the same time, 
more numerous in number. The results presented in Figure 4 are also in agreement with the 
Raman spectra reported in the other rGO studies where hydrazine hydrate was used as a 
reduction agent [26,27]. 
 
Fig. 4. Raman spectra of GO, prGO (GO partially reduced for 6 min) and rGO normalized according to Eq. 1. The 
rectangles indicate D and G bands and the ratios of their original intensities are given in the inset. 
 
The attenuation of light by GO aqueous dispersions during the reduction process was 
monitored by UV visible spectroscopy (Figure 5). The absorption spectra of GO dispersion 
exhibits two peaks at 220 nm and 310 nm which belong to specified transitions of π-π* (C=C) 
and n-π* (C=O), respectively. There is a red shift of the absorbance peak at 220 nm during the 
reduction. It can also be seen that the shoulder at 310 nm disappeared after the reduction, which 
is attributed to the decrease in concentration of carboxyl groups [8]. The color of the dispersions 
also changes during the reduction. The photo of the dispersions is given in the inset of Figure 5. 
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Fig. 5. Normalized UV-vis spectra of GO, prGO (partially reduced for 2 and 6 min) and rGO. The inset shows the 
photo of the obtained GO, prGO (partially reduced for 6 min) and rGO dispersions.  
Due to the functionalization (oxidation)-induced opening of the energy gap, GO is 
expected to exhibit photoluminescence. For the excitation in the UV part of the EM spectrum, 
GO shows pronounced fluorescence emission between 400 and 500 nm, which originates from 
radiative recombination of electron-hole pairs located in small sp2 domains [8]. The intensity of 
the PL emission strongly depends on the time of reduction of GO. It increases with reduction 
time, reaches the maximum after 6 min and then starts to decrease. The fluorescence intensity 
does not change significantly after prolonged reduction (> 10 min). As mentioned above, we will 
focus on the emission properties of the sample obtained after 6 min of reduction (prGO). PL 
spectra of the initial GO sample and GO samples reduced at different times are included in 
Supporting information (Figure S1). 
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Fig. 6. Emission excitation matrices obtained for a) GO, b) prGO and c) rGO samples. The 270 – 430 nm excitation 
and 330 – 650 nm emission wavelength ranges were used. 
 
The emission excitation matrices of the GO, prGO and rGO are shown in Figure 6. As 
can be seen, there are two distinct regions with pronounced photoluminescence intensity noted as 
region I (exc =270 nm, Δem =380 – 550 nm) and region II (exc = 300 nm, Δem = 350 – 450 
nm). Since we intended to study the interaction of GO-based nanosheets with cancer liver cells 
by DUV imaging, we were interested in the first region with excitation at 270 nm.  
Single emission spectra extracted from the emission excitation matrices for exc =270 nm 
are shown in Figure 7a.  
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Fig. 7. a) Photoluminescence (PL) emission spectra of GO, prGO and rGO obtained at exc = 270 nm. b) The same 
PL spectra normalized with respect to the maximum of the emission intensity. The rectangles indicate the emission 
ranges F1 [327 – 353 nm], F2 [370 – 410 nm] and F3 [420 – 480 nm] used in deep UV fluorescence imaging 
 
It can be seen that the partially reduced graphene oxide yields the highest fluorescence. 
Apparently, the partial reduction induced specific rearrangement of the honeycomb network 
which resulted in more effective recombination of excited electrons that further led to the 
increase in fluorescence intensity. In Figure 7b, we present the normalized photoluminescence 
spectra from Figure 7a. The grey rectangles indicate the emission ranges that are used for the 
collection of the fluorescence signal in DUV imaging: F1 [327 – 353 nm], F2 [370 – 410 nm] 
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 and F3 [420 – 480 nm]. Obviously, the maximum of emission is in F3 range, while all three GO-
based species show negligible emission in F1 range.  
3.2 DUV Fluorescence imaging of Huh7.5.1 cells incubated with GO, prGO and rGO 
Selected visible microscopy images of the control Huh7.5.1 cells and the cells incubated 
with GO, prGO and rGO are shown in Figure 8.  
 
 
Fig. 8. Bright field micrographs of control Huh 7.1.5 cells (1st column) and Huh 7.1.5 cells incubated with GO, 
prGO and rGO (2nd, 3rd and 4th columns, respectively). Red arrows indicate localization of GO, prGO and rGO at 
cell sites. Blue arrows indicate non-internalized entities. 
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 A careful analysis of the cells from various locations along the samples suggested that the 
morphology of the cells was slightly affected by the presence of GO. GO incubated cancer cells 
closely resemble the form of the control cells and folded GO aggregates rarely penetrate into the 
interior of the cells (Figure 8, the 1st and 2nd columns). In the case of the cells incubated with 
prGO and rGO, they are more affected by the presence of the nanosheets and there are numerous 
sites where the sheets are internalized in the cells. It is obvious that degree of the internalization 
strongly depends on the presence of surface ligands and, consequently, on the reduction level. 
The agglomerates of internalized reduced graphene oxides are indicated by red arrows (Figure 8 
the 3rd and 4th columns). This is in agreement with literature data, which showed that cells had 
the ability to internalize, actively fold and compartmentalize relatively large pieces of the sheets 
and remain viable [12,13,28-30].  
Deep UV imaging of treated and untreated Huh7.5.1 cancer liver cells was performed by 
using the excitation wavelength of 270 nm and the fluorescence emission was monitored in three 
spectral windows F1 [327 – 353 nm], F2 [370 – 410 nm] and F3 [420 – 480 nm]. GO, prGO and 
rGO fluorescence centers have a wide blue emission that primarily falls into the F3 range (Figure 
7b), and partially into the F2 range. The Huh7.5.1 cells have intrinsic fluorescence that has been 
detected in all three spectral emission ranges, with comparable fluorescence intensities. Bright 
field and corresponding fluorescent images of the control and incubated cells in F3 emission 
range are shown in Figure 9. In the second row of Figure 9, we show LUT fluorescent images of 
the cells, while in the fourth row are the same images normalized with respect to the highest 
intensity observed for the prGO incubated sample for comparison purposes. As can be seen, the 
fluorescence of GO-incubated is similar to the fluorescence of the control cells (Figure 9, the 2nd 
and 4th row). Also, the fluorescence emission in both samples is mainly homogeneously 
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 distributed in the cytoplasmic region. On the other hand, the fluorescence intensities of the 
prGO/Huh and rGO/Huh samples are much higher than the autofluorescence of the control 
sample. 
 
Fig. 9. Bright field microscopy (the 1st row) and corresponding DUV fluorescent images (the 2nd row) of the control 
and GO, prGO and rGO incubated Huh7.5.1 cells in F3 [420-480 nm] emission range. In the 3rd row, the green dots 
indicate the positions of the local fluorescence maxima (the positions where the intensity of the fluorescence signal 
exceeds 85% of the maximum fluorescence intensity). The 4th row shows fluorescence images of control and GO, 
prGO and rGO incubated cells normalized with respect to the maximum intensity obtained for prGO incubated cells. 
 
Page 17 of 28 AUTHOR SUBMITTED MANUSCRIPT - 2DM-102920.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ac
ce
pte
d M
an
us
cri
pt
 Furthermore, it seems that the maxima of the fluorescence coincide with the cell compartments 
containing internalized prGO and rGO species. In order to show this more clearly, we introduced 
bright field images with marked positions of the fluorescence maxima (green dots) in the third 
row of Figure 9. To establish the positions of the maxima, the signal intensities were scaled to 
include the fluorescence that exceeds >85% of the maximum intensity (the details about the 
scaling procedure and maxima selections can be found in Supporting information, Figure S2). It 
is well known that the nucleoli are the brightest intracellular autofluorescent sites [14,31] in the 
nuclei and this is indeed true for the control and GO+Huh samples (the nucleoli are indicated by 
yellow arrows). In the case of prGO+Huh and rGO+Huh samples, the maxima are positioned on 
the black entities (indicated by red arrows) suggesting that the fluorescence comes from 
internalized prGO and rGO. We have selected typical DUV fluorescent images of the control as 
well as GO, prGO and rGO incubated cells, but the similar fluorescent behavior was noticed at 
different locations along the sample (the additional images were included in Supporting 
information, Figure S3). It is important to notice that the prGO and rGO aggregates localized in 
the vicinity of the cells do not fluoresce. The lower fluorescence intensity of the prGO (or rGO) 
aggregates located outside the cell is a consequence of the agglomeration of the sheets. The 
agglomeration results in the formation of -stacked complexes, which in turn induces a static 
quenching [32]. This effect is less pronounced in the case of internalized prGO/rGO because the 
intracellular material may separate the sheets and prevent the -stacking. Further, we calculated 
the average fluorescent intensities per single cell (number of cells n > 30) for all 4 samples, 
which are presented in Figure 10. The results show that the cells with internalized prGO 
nanostructures have 2.5 times higher fluorescence intensity in F3 range than that of the control 
samples. It can also be seen that the average fluorescence intensities in all three spectral ranges 
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 decrease slightly after incubation with GO. It is possible that GO quenches the main cell 
fluorophores such as tryptophan, tyrosine, phenylalanine and NADH [33,34]. Nevertheless, the 
observed changes are within the experimental error (Figure 10). An increase in the fluorescence 
intensity of Huh7.5.1 cells incubated with rGO, relative to those treated with GO, could be 
attributed to better internalization of rGO by the cells and consequently reduced - stacking. 
These observations are confirmed by additional DUV fluorescent microscopy measurements on 
another set of samples. Obviously, the presence of the reduced GO nanostructures affects the 
overall fluorescence of the Huh7.5.1 cells. We further investigated the fluorescence dynamics 
with consecutive imaging of the treated and untreated cells. 
 
Fig. 10. The average fluorescent intensity per single cell for untreated Huh7.5.1 cells (control), as well as GO, prGO 
and rGO, incubated Huh7.5.1 cells (number of cells counted n > 30). The error bars represent standard deviations of 
the fluorescence intensity. 
 
Selected local fluorescent maxima are followed in the time-lapse experiment (see Figure S4 in 
Supporting information for details). The time dependence of the average intensity of local 
maxima (normalized according to Eq. 1) in F1, F2 and F3 emission ranges are shown in 
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 Figure 11. The original average intensities at particular time intervals and the standard deviations 
are given in Supporting information (Table S1). 
 
Fig. 11. The dependences of the average intensities of local maxima (normalized according to Eq. 1) from time in a) 
F1 [327-353 nm] b) F2 [370-410 nm] and c) F3 [420-480 nm] emission ranges. D) The evolution of the fluorescent 
signal that comes from the autofluorophores (fluorescent maxima previously fixed by observing the fluorescence in 
the F1 range) and from prGO fluorophores in the F3 range (the details about the procedure of finding maxima are 
explained in the Supporting information, Figure S5). The curve that corresponds to control Huh cells in c) is also 
included in d) for comparison. 
 
It can be seen that the presence of graphene oxide based species does not influence the 
fluorescence kinetics significantly in F1 range. The incubated and control cells show similar 
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 time-dependence of the fluorescence intensity (Figure 11a). The fluorescent intensity decreases 
with prolonged time, with the slowest decay noticed in the case of the prGO+Huh cells. The time 
dependence of the fluorescence intensity does not change significantly when the detection was 
switched from F1 to F2 window (Figure 11b). The intensity decreases with time in this range as 
well. However, the degrees of changes are more pronounced. Also, the fastest intensity decay 
was observed for the GO incubated cells and it should be attributed to the GO-induced emission 
quenching of tryptophan-containing species mentioned above [33]. In the F3 range (Figure 11c), 
the dependence of the fluorescence intensity from time is somewhat different. As can be seen in 
Figure 11c, the normalized fluorescence intensity of the control cells increases with time. Their 
fluorescence mostly originates from the presence of NADH, which exhibits maximum 
fluorescence in this range [15]. Also, the time dependence of the fluorescence intensity of the 
pure NADH material [35] is similar to that of the control cells observed in Figure 11c. 
It should also be noticed that the fluorescence of the cells incubated with graphene oxide 
increases almost linearly with time, while the increase itself is slower than that observed for the 
untreated cells. On the other hand, the reduced graphene oxides (prGO and rGO) affect the 
fluorescence dynamics differently. The time-lapse experiments show that the fluorescence 
intensities of prGO and rGO incubated cells reach maxima after approximately 6 minutes and 
then start to decrease (Figure 11c). The obtained results apparently show that GO, prGO and 
rGO nanosheets affect the fluorescence dynamics in a different way. GO obviously interacts with 
the cells’ autofluorophores, tryptophan (main fluorescence in the F2 range) and NADH (main 
fluorescence in the F3 range), and induces partial quenching through non-radiative processes. 
The time-lapse measurements in the F3 range showed the presence of two general processes in 
the fluorescence of prGO and rGO incubated Huh7.5.1 cells in contrast to the continuous 
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 increasing of the fluorescence of the control cells. In Figure 11d, we tried to follow the time 
dependence of the fluorescence intensities of the autofluorophore (NADH) and fluorophore 
prGO in the prGO incubated cells separately. The details of the procedure are explained in the 
Supporting information (Figure S5). Briefly, the positions of the fluorescence maxima in F1 
range (which correspond almost exclusively to the fluorescence of the autofluorophores) were 
fixed. After that, the time evolution of these fluorescence centers was followed in the F3 range 
together with the time evolution of strongest fluorescence centers in the same range (which 
coincide with the positions of prGO sheets). As the results in Figure 11d show, the fluorescence 
dynamics of the autofluorophores in the F3 range closely resembles the dynamics of control cells 
in the same range. The fluorescence intensity is increasing with time until it reaches saturation. 
This suggests that the change in fluorescence dynamics of prGO+Huh cells with respect to that 
of the control cells is indeed the consequence of the presence of prGO fluorophores. A deeper 
understanding of the effects of prGO on the time evolution of fluorescent signal would require a 
separate study. Nevertheless, the presented results (Figures 9 and 10) clearly show that the 
average fluorescence intensity of the cells significantly increases if they are incubated with prGO 
sample. Since it contains both sp2 and sp3 domains, it may interact with aromatic ring containing 
drugs through π-π stacking but also with polar molecules via epoxide, hydroxyl, and carboxylic 
groups. This is why we believe that prGO can also be used in drug delivery applications. The 
successful delivery of the drug conjugated to prGO nanosheets might be monitored by 
fluorescence imaging and we plan to continue our research in this direction.  
 
4. Conclusion 
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 In this article, DUV fluorescence spectroscopy was used to study the interaction of partially 
reduced graphene oxide with the cancer liver cells. A modified Hummers method was used for 
the fabrication of graphene oxide and the reduction was performed in the presence of hydrazine 
hydrate. The partial reduction of graphene oxide was achieved by controlling the duration of the 
reduction process. It was found that the sample partially reduced for 6 min showed the highest 
fluorescence intensity and it was further used in bioimaging tests. GO, prGO and rGO samples 
were studied using various microscopy and spectroscopic methods in order to establish their 
structure and physical properties. STEM micrographs of GO, prGO and rGO showed the 
presence of isolated monolayers. Elemental analysis revealed that the C/O ratio values were 
dependent on the time of reduction, which was also confirmed by Raman spectroscopy. The 
change in the optical properties was monitored by photoluminescence and UV-vis 
spectroscopies. The partially reduced graphene oxide showed the highest intensity of 
photoluminescence emission for the excitation that belongs to the DUV part of the EM spectrum. 
The fluorescent GO, prGO and rGO nanostructures were used in the DUV fluorescence imaging 
study of the cancer liver cell line Huh7.5.1. The interaction of the prGO nanostructures with the 
cells resulted in a strong increase in the fluorescence intensity in F3 [420-480 nm] range with 
respect to the autofluorescence of the control sample. Time-lapse studies showed that the time 
dependence of the fluorescence emission from GO, prGO and rGO internalized cells is different 
from that of the intrinsic fluorescence of the untreated cells. The prGO nanostructure was 
suggested as a possible carrier for cancer drugs since its pronounced fluorescence might be used 
for monitoring the delivery process. In the forthcoming study, we will focus on the drug 
conjugated-prGO nanostructures and their interaction with cancer cells.  
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